Nextleaf Solutions Ltd. (TSE:OILS)
:OILS
Top Page
Nextleaf Solutions
(OILS)
Select Model
Select Model
Rating:61Neutral
Price Target:
C$0.07
▲(38.00% Upside)
Action:ReiteratedDate:03/06/26
The score is driven mainly by improving fundamentals (rapid revenue growth, low leverage, and positive recent cash flow), but capped by still-unstable profitability and thin/declining margins. Technicals are supportive with price above moving averages, yet overbought readings (RSI/Stoch) temper the outlook. Valuation helps with a low P/E, though no dividend yield is available.
Positive Factors
Improving cash generation
The company recorded positive EBITDA and free cash flow in 2025, reversing prior cash losses. Durable positive operating cash flow supports reinvestment in processing capacity and IP monetization, reducing reliance on external financing over the next several quarters.
Negative Factors
Revenue contraction
Top-line shrinkage undermines operating leverage and compresses margin recovery because fixed processing and IP development costs remain. Sustained revenue declines would challenge return to consistent profitability and slow the pace of strategic reinvestment.
Read all positive and negative factors
Positive Factors
Negative Factors
Improving cash generation
The company recorded positive EBITDA and free cash flow in 2025, reversing prior cash losses. Durable positive operating cash flow supports reinvestment in processing capacity and IP monetization, reducing reliance on external financing over the next several quarters.
Read all positive factors
Nextleaf Solutions (OILS) vs. iShares MSCI Canada ETF (EWC)
Market Cap
C$8.44M
Dividend YieldN/A
Average Volume (3M)144.15K
Price to Earnings (P/E)8.9
Beta (1Y)1.27
Revenue Growth-1.14%
EPS GrowthN/A
CountryCA
Employees26
SectorHealthcare
Sector Strength45
IndustryDrug Manufacturers - Specialty & Generic
Share Statistics
EPS (TTM)N/A
Shares Outstanding168,819,810
10 Day Avg. Volume211,934
30 Day Avg. Volume144,145
Financial Highlights & Ratios
PEG Ratio0.81
Price to Book (P/B)2.55
Price to Sales (P/S)1.04
P/FCF Ratio33.06
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Nextleaf Solutions Business Overview & Revenue Model
Company Description
Nextleaf Solutions Ltd., a cannabis extraction technology company, develops and licenses technology for the extraction, distillation, and formulation of cannabinoids in Canada. The company extracts, distills, purifies, delivers, and wholesales CBD...
How the Company Makes Money
Nextleaf Solutions generates revenue through multiple streams, including the sale of its proprietary extraction technology, which allows cannabis producers to efficiently extract cannabinoids from raw plant material. Additionally, the company capi...
Nextleaf Solutions Financial Statement Overview
Summary
Income Statement
44
Neutral
Balance Sheet
72
Positive
Cash Flow
67
Positive
| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 11.26M | 12.48M | 8.18M | 4.41M | 3.38M |
| Gross Profit | 1.94M | 3.74M | 2.31M | 661.24K | -855.03K |
| EBITDA | 611.70K | -624.44K | 1.14M | -1.94M | -3.79M |
| Net Income | -162.94K | -1.44M | 223.33K | -3.49M | -5.39M |
Balance Sheet | |||||
| Total Assets | 7.82M | 8.57M | 8.54M | 7.15M | 9.19M |
| Cash, Cash Equivalents and Short-Term Investments | 446.56K | 438.54K | 898.90K | 377.72K | 915.38K |
| Total Debt | 793.82K | 384.69K | 489.75K | 1.36M | 3.25M |
| Total Liabilities | 3.25M | 4.06M | 4.40M | 4.14M | 5.77M |
| Stockholders Equity | 4.57M | 4.50M | 4.13M | 3.02M | 3.43M |
Cash Flow | |||||
| Free Cash Flow | 353.16K | -682.48K | 851.89K | -911.02K | -2.94M |
| Operating Cash Flow | 414.88K | -614.09K | 875.46K | -802.19K | -2.87M |
| Investing Cash Flow | -267.79K | -68.39K | -23.56K | -108.83K | -21.48K |
| Financing Cash Flow | -139.06K | 222.12K | -330.71K | 373.35K | 2.82M |
Nextleaf Solutions Technical Analysis
Negative
0.05
Price Trends
0.05
Negative
0.05
Negative
0.06
Negative
Market Momentum
>-0.01
Positive
42.70
Neutral
16.67
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TSE:OILS, the sentiment is Negative. The current price of 0.05 is below the 20-day moving average (MA) of 0.06, below the 50-day MA of 0.05, and below the 200-day MA of 0.06, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 42.70 is Neutral, neither overbought nor oversold. The STOCH value of 16.67 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for TSE:OILS.
Nextleaf Solutions Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
67 Neutral | C$182.75M | 36.96 | 11.63% | ― | 30.64% | 101.12% | |
61 Neutral | C$8.44M | 8.94 | 11.57% | ― | -1.14% | ― | |
54 Neutral | C$260.40M | 3.90 | 4.86% | ― | 62.15% | 60.50% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
50 Neutral | C$59.88M | -2.97 | -19.76% | ― | 26.91% | 81.01% | |
49 Neutral | C$27.35M | -3.31 | -19.10% | ― | 18.06% | 34.58% |
* Healthcare Sector Average
TSE:OILS
Nextleaf Solutions
0.05
>-0.01
-16.67%
TSE:ATLE
Willow Biosciences Inc
0.17
0.12
246.94%
TSE:OGI
Organigram Global
1.91
0.55
40.44%
TSE:LABS
MediPharm Labs
0.07
-0.02
-23.53%
TSE:LOVE
Cannara Biotech
1.85
0.65
54.17%
TSE:HASH
Simply Solventless Concentrates Ltd
0.05
-0.60
-92.97%
Nextleaf Solutions Corporate Events
Business Operations and StrategyFinancial Disclosures
Nextleaf Solutions Posts Profitable Q1 FY26 with Strong Cash Flow and Brand Expansion
Positive
Mar 3, 2026
Nextleaf Solutions reported Q1 FY26 gross revenue of about CAD $4 million, net revenue of CAD $3.0 million, and gross profit of CAD $1.29 million, delivering a 43% gross margin and net income of CAD $259,171. The company posted its fifth consecuti...
Business Operations and Strategy
Nextleaf Taps Kindred and New Distributors to Scale Cannabis CPG Platform
Positive
Feb 19, 2026
Nextleaf Solutions has overhauled its commercial platform to support scalable, margin-focused growth in its Canadian cannabis consumer-packaged goods business. The company appointed Kindred Canada as its national sales agency partner, shifting fro...
Business Operations and StrategyProduct-Related Announcements
Nextleaf Ships Cannabis Softgels to Australia as It Expands Global Partners Program
Positive
Feb 13, 2026
Nextleaf Solutions has completed its first commercial shipment of 756,000 cannabis softgels to a white-label client in Australia, marking a significant step in its international expansion. The move highlights the company’s export-ready infra...
Business Operations and StrategyFinancial Disclosures
Nextleaf Narrows Loss, Turns EBITDA Positive as Premium Cannabis Extract Strategy Pays Off
Positive
Jan 29, 2026
Nextleaf Solutions reported a transformative fiscal 2025, highlighted by an 88.6% reduction in annual net loss to $162,944, improved gross margins to 25%, and a swing to positive EBITDA of $522,258 alongside positive operating cash flow, despite s...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.